TeVido took 3rd place in The RESI Innovation Challenge, showcasing cutting-edge life science technologies in poster displays. The Redefining Early Stage Investments (RESI) Conference is for early stage life sciences companies to source investors, create relationships, and eventually, get funding.
Photo: Alejandro Zamorano, Director of Business Development, LSN | Laura Bosworth, CEO & co-founder, TeVido BioDevices | Scott Collins, CTO & VP of Research and Development, TeVido BioDevices | Michael Quigley, Director of Research, LSN.
CNBC and Singularity University invited some of the most exciting early stage companies in the world and brought them to Exponential Finance 2015 XCS Challenge. TeVido was named as a top 5 contender in the Health and Medicine category and had the opportunity to pitch at the event.
Watch CNBC Interview of CEO, Laura Bosworth
Springboard to a Healthier Future: TeVido BioDevices’ CEO and Co-Founder, Laura Bosworth, Joins Powerhouse Network of Women Entrepreneurial Leaders: 11 Companies Access Expert Network to Commercialize Disruptive Health Solutions
For over 15 years Springboard Enterprises has served as an on-ramp for over 550 of the most promising high tech companies led by women. The eleven (11) companies in the 2015 Health Innovation Hub class join the Springboard portfolio and will have ready access to Springboard’s vast expert network of corporate partners, industry experts, veteran entrepreneurs and investors. Read More
TeVido BioDevices won $25,000 in prize money at the Inaugural Texas New Ventures Competition, hosted by Texas A&M . The competition, which attracted more than 90 young companies, promoted the commercialization of emerging technology by recognizing companies with high growth potential. TeVido won two separate awards.
TeVido wins Michael E. DeBakey Memorial Life Science Award at the 2015 Texas Life Science Forum hosted by BioHouston and The Rice Alliance for Technology & Entrepreneurship
This award is given annually to recognize an undiscovered, emerging life science company from Texas that has demonstrated innovation and the highest potential to commercialize their important product. TeVido was chosen for the award from a field of more than 50 companies and technologies that presented at the conference.
Photo (L to R): Dr. Scott Collins, TeVido VP R&D, Jacqueline Northcut CEO of BioHouston and Texas BioAlliance, Laura Bosworth, CEO TeVido.